U.S. Electrical Stock News

Helmerich & Payne (HP) is back in focus after its board declared a quarterly cash dividend of $0.25 per share, payable on June 1, 2026, to shareholders of record on May 18. See our latest analysis for Helmerich & Payne. The latest dividend decision comes as investor interest has already been rising, with a 30.39% 90 day share price return and 19.07% year to date share price return at a last close of $35.65. The 1 year total shareholder return of 47.05% points to momentum that has been...

If you are wondering whether Waste Connections at around US$166 per share still offers fair value, the key is to separate short term noise from what the current price actually reflects. The stock has seen a 3.0% gain over the last 30 days, but that sits against a 4.4% year to date decline and a 10.7% decline over the past year, which naturally raises questions about how the market is reassessing its prospects and risks. Recent attention on the commercial services space, including Waste...

Earlier this month, Ryman Hospitality Properties and its affiliates issued US$700 million of 5.750% senior unsecured notes due 2034 under a new indenture, with the company planning to use the proceeds and available cash to redeem in full its existing US$700 million 4.750% senior notes due 2027. This refinancing not only pushes out a major maturity but also tightens operating and financing covenants, reshaping Ryman’s balance sheet flexibility and creditor protections through 2034. Next,...

Earlier this month, Progressive’s board declared a US$0.10 per-share common dividend, payable on April 10, 2026, to shareholders of record as of April 2, 2026, underscoring its ongoing capital return program. At the same time, Progressive announced the upcoming retirement of long-serving CFO John Sauerland and the planned handover to current Chief Strategy Officer Andrew Quigg, a leadership shift that could shape how the insurer balances growth investments, pricing discipline, and...

Why Kinder Morgan is on investors’ radar today Kinder Morgan (KMI) is drawing attention after recent performance data showed a 3.3% return over the past month and a 26.8% total return over the past 3 months, against a last close of US$33.39. See our latest analysis for Kinder Morgan. That recent 3 month share price return sits alongside a 20.5% year to date share price return and a 25.3% 1 year total shareholder return, suggesting momentum has been building over both shorter and longer...

Aon (AON) recently completed what it describes as the first stablecoin insurance premium payment among major global brokers, using USDC on Ethereum and PayPal USD on Solana with clients Coinbase and Paxos. See our latest analysis for Aon. At a share price of $321.41, Aon has seen recent momentum soften, with a 90 day share price return of 8.64% and a 1 year total shareholder return of 17.09%. The 5 year total shareholder return of 49.65% points to meaningfully stronger long run compounding...

The Andersons, Inc. recently reported quarterly earnings that exceeded analyst expectations on earnings per share even as revenue fell year-on-year, while its CEO’s 2025 compensation rose to an estimated US$5,472,539 alongside insider stock sales and shifting institutional positions. At the same time, Middle East shipping disruptions have tightened global grain and fertilizer supply, lifting prices and potentially improving margin prospects for Andersons’ Agribusiness and Renewables...

Wondering if FTI Consulting at around US$162.58 is fairly priced, too expensive, or offering value right now? This article walks through the key signals you can use to judge that for yourself. The stock has been under some pressure recently, with a 3.0% decline over the last week, a flat 0.1% slip over the past month, and returns of 4.5% lower year to date and 0.7% lower over the past year, even though the 5 year return sits at 18.5%. These moves sit against a backdrop of ongoing interest in...

HealthEquity recently reported its Q4 fiscal 2026 results after Wall Street had forecast earnings of US$0.89 per share on revenue of US$332.85 million, with expectations for earnings growth and continued expansion in its health savings account and benefits administration business. Investor attention has centered on whether HealthEquity could extend its pattern of topping consensus estimates, making this earnings release a key indicator of the company’s ability to sustain account growth and...

Earlier this month, Commvault announced an integration with CloudSEK that feeds dark web credential intelligence into its Active Directory security tools, alongside an expansion of its Identity Resilience portfolio to support rapid recovery of Okta environments from misconfigurations, disruptions, and identity-driven attacks. Together, these moves highlight Commvault’s push deeper into identity-centric cyber resilience, aiming to tie external credential exposure data directly to internal...

In early March 2026, Aramark Refreshments opened its first Alabama Market Center in Madison and Aramark Sports + Entertainment partnered with the Las Vegas A’s and restaurateur Will Guidara on premium hospitality concepts for the team’s planned 2028 ballpark. Together, these moves extend Aramark’s on-the-ground presence in the Southeast while deepening its role in high-end sports hospitality, linking local workforce initiatives with upscale, experience-led offerings. We’ll now examine how...

RadNet (RDNT) is back in focus after executives used the Barclays Global Healthcare Conference to outline 2026 targets for revenue and EBITDA growth, centered on advanced imaging and broader use of AI-enabled solutions. See our latest analysis for RadNet. After a sharp share price pullback in recent months, including a 10.7% 1 month share price return and 12.8% 3 month share price return, RadNet’s 1 year total shareholder return of 26.7% and very large 5 year total shareholder return suggest...

What Stands Out About Ocular Therapeutix Right Now Ocular Therapeutix (OCUL) has drawn fresh attention after a period where the share price shows mixed returns, including a 1 day decline of 1.2% and a loss of 14.7% over the past week. At a recent close of US$8.76 and a market value of about US$1.9b, the company sits at an interesting point for investors comparing its current pricing with its business profile and recent financial results. See our latest analysis for Ocular Therapeutix. The...

Over the past two weeks, Intel has deepened its role in AI and next‑generation networks through new alliances with Viettel, Ericsson and Infosys, while its confidential computing technology was validated in production deployments and Craig H. Barratt was elected as the company’s next independent chair. Taken together, these moves position Intel more firmly at the intersection of AI infrastructure, 5G/6G architectures and secure data processing, potentially reinforcing its relevance across...

Nuvation Bio recently filed a US$125.34 million shelf registration for 21,462,599 shares of Class A common stock related to its employee stock ownership plans, shortly after reporting fourth-quarter 2025 revenue of US$41.87 million and a net loss of US$36.59 million. Alongside sharply higher full-year 2025 revenue of US$62.9 million and a much smaller annual net loss of US$204.63 million, the company entered an exclusive licensing and collaboration agreement with Eisai for taletrectinib...

MKS Instruments (NasdaqGS:MKSI) has received official validation of its near term greenhouse gas emissions reduction targets from the Science Based Targets initiative (SBTi). The validation confirms that MKS's climate goals are aligned with internationally recognized criteria for science based climate action. This development strengthens the company's environmental, social and governance (ESG) profile at a time when customers and investors are increasingly focused on sustainability. MKS...

In recent days, Oscar Health, Inc. drew attention as analysts highlighted expected year-over-year earnings growth, robust revenue expansion and improved cost controls ahead of its latest earnings release. Amid these developments, an upgrade from Raymond James and continued support from large institutional investors underscored growing confidence in Oscar Health’s margin outlook despite industry pressures. Against this backdrop, we’ll explore how analyst optimism around Oscar’s margin...

Earlier this month, Gap reported fourth-quarter 2025 sales of US$4,236 million and full-year sales of US$15,366 million, alongside slightly lower net income and earnings per share versus the prior year. On the same day, the company issued guidance for modest net sales growth in fiscal 2026 and unveiled a new US$1 billion share repurchase authorization after completing a prior buyback program that retired 39,828,667 shares. Now we’ll explore how Gap’s new US$1 billion buyback authorization...

Aptiv (APTV) is reshaping its business with the planned spin-off of its Electrical Distribution Systems unit into Versigent, supported by a US$1.35b notes tender offer and new long-term debt issuance. See our latest analysis for Aptiv. Despite the upcoming Versigent spinoff and recent debt tender and issuance, Aptiv’s 1 month share price return of 17.25% and year to date share price decline of 10.12% suggest momentum has cooled, while the 1 year total shareholder return of 12.53% contrasts...

Rigetti Computing postponed the general release of its 108 qubit Cepheus 1 108Q system to the end of Q1 2026 to allow more testing and hardware tuning. The delay comes shortly after major contract wins in India and Japan that rely on Rigetti’s quantum hardware roadmap. New insider filings show recent stock sales by two executives, drawing attention to timing and confidence as the company adjusts its rollout plan. For investors tracking NasdaqCM:RGTI, this update arrives after a very large 3...

Duke Energy recently completed a US$1.30 billion private offering of 3.000% convertible senior notes due 2029 and put in place an at-the-market program to sell up to US$6.00 billion of common stock over time. Together, these moves significantly expand Duke’s financing toolkit, giving it flexibility to fund its enlarged US$103.00 billion five-year capital plan while potentially increasing future share count. We’ll now examine how this expanded use of equity and convertible debt could reshape...

CME Group (CME) stock is back in focus after CEO Terry Duffy warned that US government intervention in oil futures to curb prices could trigger a “biblical disaster” for market confidence and commodity pricing. See our latest analysis for CME Group. Beyond the headlines, CME Group’s recent client partnerships and new South Asia edible oil futures contracts sit alongside a 90 day share price return of 14.09% and a 1 year total shareholder return of 22.66%. Together, these figures suggest...

In early March 2026, AMD announced it had expanded its collaboration with Flex to manufacture the AMD Instinct MI355X AI platform in the US, with production already underway at Flex’s 1.40 million-square-foot Austin, Texas headquarters and volume ramp expected the following quarter. This move underscores Flex’s role in building complete, high-density AI hardware systems, including liquid-cooled, eight-GPU platforms, for large-scale data center deployments, deepening its position in advanced...

Choice Hotels International (CHH) has been in focus after reporting a quarter in which revenue beat analyst expectations by 5.4% and profitability reached record levels, even as the stock declined following the earnings release. See our latest analysis for Choice Hotels International. Despite the record quarter, sentiment has been cautious, with the 30 day share price return of 13.25% and a 1 year total shareholder return of 27.15% decline, suggesting momentum has been fading rather than...